Form 4: Director Donald Berwick Receives NRC Health Stock Award

NRC Health Director Donald Berwick was granted restricted stock units valued at $150,000, vesting in 2027.

Summary

• Donald M. Berwick, a Director at NRC Health, received an award of 7,697 shares of common stock on June 23, 2026.
• This award is part of his annual equity compensation under the Issuer's 2025 Omnibus Incentive Plan.
• The grant's value was $150,000, calculated by dividing this amount by the closing stock price on the day before the Issuer's 2026 annual meeting.
• The restricted stock units will vest and become exercisable on the date of the Issuer's 2027 annual stockholder meeting, subject to standard vesting and forfeiture provisions.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive filing, reflecting standard compensation practices for a director rather than significant new financial performance or strategic shifts.

Positives

• Director Donald Berwick received a significant equity award, indicating continued investment in management and board alignment with shareholder interests.
• The award is structured under an existing incentive plan, suggesting a consistent approach to executive compensation.
• The value of the award ($150,000) reflects a commitment to retaining and motivating key leadership.

Negatives

• The exact number of shares granted (7,697) is dependent on the stock price at a specific future date, introducing some variability in the precise share count at the time of the grant.
• Vesting is contingent on continued service until the 2027 annual meeting, meaning the award could be forfeited if the director leaves before then.

Risks

• The value of the stock award is subject to market fluctuations until it vests.
• Forfeiture risk exists if Donald M. Berwick does not remain a director until the 2027 annual stockholder meeting.

Future Outlook

The award is set to vest and become exercisable on the date of the Issuer's 2027 annual stockholder meeting, subject to the terms of the Issuer's 2025 Omnibus Incentive Plan.

Management Comments

• "This share award represents annual equity compensation in the form of a grant of restricted stock units equal to $150,000, divided by the closing price on the date immediately preceding the Issuer's 2026 annual meeting of stockholders, under the Issuer's 2025 Omnibus Incentive Plan."
• "The award will vest and become exercisable on the date of the Issuer's 2027 annual stockholder meeting, subject to vesting, forfeiture, and termination provisions."

Industry Context

StockSavvy.ai notes that equity awards to directors are a common practice in the healthcare technology sector to align leadership incentives with long-term company performance and shareholder value.

Stakeholder Impact

• Shareholders: The award reinforces alignment between director compensation and company performance, potentially benefiting shareholders through motivated leadership.
• Employees: Standard compensation practices can contribute to overall employee morale and retention.
• Management: The award is a form of compensation for the director's service.

Next Steps

• Vesting of the restricted stock units on the date of the Issuer's 2027 annual stockholder meeting.
• Potential exercise of vested shares by Donald M. Berwick.

Key Dates

Keywords

NRC Health, Form 4, Stock Award, Restricted Stock Units, Equity Compensation, Director, Donald M. Berwick, Omnibus Incentive Plan, Vesting, SEC Filing